BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $658,752 | -18.8% | 17,455 | -2.0% | 0.01% | -16.7% |
| Q2 2023 | $811,196 | +12.6% | 17,805 | +0.2% | 0.01% | +20.0% |
| Q1 2023 | $720,467 | -22.6% | 17,763 | -2.7% | 0.01% | -28.6% |
| Q4 2022 | $930,865 | -5.4% | 18,263 | -0.1% | 0.01% | -12.5% |
| Q3 2022 | $984,000 | -14.3% | 18,273 | +2.2% | 0.01% | -11.1% |
| Q2 2022 | $1,148,000 | -20.0% | 17,873 | -3.4% | 0.01% | 0.0% |
| Q1 2022 | $1,435,000 | -9.1% | 18,503 | +0.6% | 0.01% | -10.0% |
| Q4 2021 | $1,579,000 | +6.8% | 18,393 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,479,000 | -0.1% | 18,393 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,480,000 | -4.6% | 18,393 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,551,000 | +4.0% | 18,393 | -1.1% | 0.01% | -9.1% |
| Q4 2020 | $1,492,000 | -1.8% | 18,593 | -1.6% | 0.01% | -15.4% |
| Q3 2020 | $1,519,000 | -0.3% | 18,893 | +6.8% | 0.01% | -7.1% |
| Q2 2020 | $1,524,000 | +2.1% | 17,693 | -3.8% | 0.01% | -12.5% |
| Q1 2020 | $1,493,000 | -6.6% | 18,393 | -3.8% | 0.02% | +33.3% |
| Q4 2019 | $1,598,000 | -5.4% | 19,118 | -1.0% | 0.01% | -14.3% |
| Q3 2019 | $1,689,000 | +3.6% | 19,318 | -3.0% | 0.01% | -6.7% |
| Q2 2019 | $1,631,000 | +0.7% | 19,913 | 0.0% | 0.02% | -6.2% |
| Q1 2019 | $1,619,000 | +22.0% | 19,913 | -1.3% | 0.02% | +6.7% |
| Q4 2018 | $1,327,000 | -16.1% | 20,175 | -1.7% | 0.02% | +7.1% |
| Q3 2018 | $1,582,000 | +4.4% | 20,525 | +0.1% | 0.01% | 0.0% |
| Q2 2018 | $1,515,000 | +4.1% | 20,513 | -8.3% | 0.01% | 0.0% |
| Q1 2018 | $1,455,000 | -4.1% | 22,363 | -4.7% | 0.01% | 0.0% |
| Q4 2017 | $1,517,000 | -3.2% | 23,463 | -6.0% | 0.01% | -12.5% |
| Q3 2017 | $1,567,000 | +1.4% | 24,973 | -2.2% | 0.02% | -5.9% |
| Q2 2017 | $1,545,000 | +7.9% | 25,523 | -7.6% | 0.02% | +13.3% |
| Q1 2017 | $1,432,000 | +16.1% | 27,627 | -0.7% | 0.02% | +7.1% |
| Q4 2016 | $1,233,000 | -7.1% | 27,810 | -0.2% | 0.01% | -12.5% |
| Q3 2016 | $1,327,000 | -3.5% | 27,877 | -8.3% | 0.02% | -5.9% |
| Q2 2016 | $1,375,000 | -30.0% | 30,411 | -36.4% | 0.02% | -37.0% |
| Q1 2016 | $1,964,000 | -40.0% | 47,811 | -44.3% | 0.03% | -40.0% |
| Q4 2015 | $3,273,000 | +11.5% | 85,811 | -4.0% | 0.04% | 0.0% |
| Q3 2015 | $2,936,000 | -41.8% | 89,361 | +23.8% | 0.04% | -32.8% |
| Q2 2015 | $5,047,000 | +4.8% | 72,161 | +2.6% | 0.07% | -1.5% |
| Q1 2015 | $4,816,000 | -10.7% | 70,309 | -4.5% | 0.07% | -12.8% |
| Q4 2014 | $5,395,000 | -90.7% | 73,619 | -90.9% | 0.08% | -91.1% |
| Q2 2014 | $58,204,000 | +3.4% | 805,042 | +5.2% | 0.87% | -2.6% |
| Q1 2014 | $56,312,000 | +32.4% | 765,325 | +25.1% | 0.90% | +26.9% |
| Q4 2013 | $42,535,000 | +13.2% | 611,574 | +6.9% | 0.71% | -2.2% |
| Q3 2013 | $37,583,000 | +68.6% | 572,130 | +77.8% | 0.72% | +53.3% |
| Q2 2013 | $22,293,000 | – | 321,828 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |